{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T16:05:48Z","timestamp":1649088348474},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[1986,8,1]],"date-time":"1986-08-01T00:00:00Z","timestamp":523238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1986,8]]},"DOI":"10.1007\/bf01712054","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T06:18:49Z","timestamp":1118557129000},"page":"695-700","source":"Crossref","is-referenced-by-count":1,"title":["Ergebnisse einer 5-Jahres-Studie mit Captopril bei Patienten mit schwerer therapieresistenter Hypertonie"],"prefix":"10.1007","volume":"64","author":[{"given":"J.","family":"Schrader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Schoel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Scheler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01712054_CR1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.0954-6820.1985.tb01651.x","volume":"217","author":"L Andren","year":"1985","unstructured":"Andren L, Karlberg BE, Svensson A, \u00d6hmen P, Nilsson OR, Hansson L (1985) Long-term effects of Captopril and Atenolol in essential hypertension. Acta Med Scand 217:155\u2013160","journal-title":"Acta Med Scand"},{"key":"BF01712054_CR2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(79)92186-X","volume":"II","author":"AB Atkinson","year":"1979","unstructured":"Atkinson AB, Robertson JIS (1979) Captopril in the treatment of clinical hypertension and cardiac failure. Lancet II:836\u2013839","journal-title":"Lancet"},{"key":"BF01712054_CR3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(80)90001-X","volume":"II","author":"AB Atkinson","year":"1980","unstructured":"Atkinson AB, Lever AF, Brown JJ, Robertson JIS (1980) Combined treatment of severe intractable hypertension with Captopril and diuretic. Lancet II:105\u2013108","journal-title":"Lancet"},{"key":"BF01712054_CR4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/01.HYP.2.1.73","volume":"2","author":"KM Baker","year":"1980","unstructured":"Baker KM, Johns DW, Ayers CR, Carey RM (1980) Ischemic cardiovascular complications concurrent with administration of Captopril. A clinical note. Hypertension 2:73\u201374","journal-title":"Hypertension"},{"key":"BF01712054_CR5","first-page":"411","volume":"39","author":"A Breckenridge","year":"1970","unstructured":"Breckenridge A, Dollery CT, Parry EHD (1970) Prognosis of treated hypertension. Quart J Med 39:411\u2013429","journal-title":"Quart J Med"},{"key":"BF01712054_CR6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-90-1-19","volume":"90","author":"HR Brunner","year":"1979","unstructured":"Brunner HR, Gavras H, Waeber B, Kershaw GR, Turini G, Vukovich R, McKinstry DN, Gavras J (1979) Oral angiotensin-converting-enzyme inhibitor in long-term treatment of hypertensive patients. Ann Intern Med 90:19\u201323","journal-title":"Ann Intern Med"},{"key":"BF01712054_CR7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/01.CIR.64.4.765","volume":"64","author":"DB Case","year":"1981","unstructured":"Case DB, Atlas SA, Sullivan PA, Laragh JH (1981) Acute and chronic treatment of severe and malignant hypertension with the oral angiotensin-converting-enzyme inhibitor Captopril. Circulation 64:765\u2013771","journal-title":"Circulation"},{"key":"BF01712054_CR8","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/0002-9149(82)90358-7","volume":"49","author":"DB Case","year":"1982","unstructured":"Case DB, Atlas SA, Marion RM, Laragh JH (1982) Long-term efficacy of Captopril in renovascular and essential hypertension. Am J Cardiol 49:1440\u20131446","journal-title":"Am J Cardiol"},{"key":"BF01712054_CR9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/0002-9343(81)90170-4","volume":"71","author":"RJ Cody","year":"1981","unstructured":"Cody RJ, Bravo EL, Fouad FM, Tarazi RC (1981) Cardiovascular reflexes during long-term converting enzyme inhibition and sodium depletion. Am J Med 71:422\u2013426","journal-title":"Am J Med"},{"key":"BF01712054_CR10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinte.1983.00350040049004","volume":"143","author":"RC Cooper","year":"1983","unstructured":"Cooper RC (1983) Captopril-associated neutropenia. Arch Intern Med 143:659\u2013660","journal-title":"Arch Intern Med"},{"key":"BF01712054_CR11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0140-6736(85)90975-4","volume":"I","author":"CRW Edwards","year":"1985","unstructured":"Edwards CRW, Padfield PL (1985) Angiotensin-converting-enzyme inhibitors. Past, present and bright future. Lancet I:30\u201335","journal-title":"Lancet"},{"key":"BF01712054_CR12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0002-8703(80)90730-9","volume":"99","author":"RK Ferguson","year":"1980","unstructured":"Ferguson RK, Vlasses PH, Koplin JR, Shirinian A, Barke JF, Alexander JC (1980) Captopril in severe treatment-resistant hypertension. Am Heart J 99:579\u2013585","journal-title":"Am Heart J"},{"key":"BF01712054_CR13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00548761","volume":"26","author":"Z Gl\u00fcck","year":"1984","unstructured":"Gl\u00fcck Z, Beretta-Piccoli C, Reubi FC (1984) Long-term effects of Captopril on renal function in hypertensive patients. Euro J Clin Pharmacol 26:315\u2013323","journal-title":"Euro J Clin Pharmacol"},{"key":"BF01712054_CR14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bmj.290.6475.1111","volume":"290","author":"MJ Goodfield","year":"1985","unstructured":"Goodfield MJ, Millard LG (1985) Severe cutaneous reactions to Captopril. Brit Med J 290:1111","journal-title":"Brit Med J"},{"key":"BF01712054_CR15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0140-6736(79)90191-0","volume":"II","author":"KG Green","year":"1979","unstructured":"Green KG (1979) Optimised blood-pressure. Lancet II:33","journal-title":"Lancet"},{"key":"BF01712054_CR16","first-page":"5280","volume":"31","author":"J-H Gr\u00f6ne","year":"1981","unstructured":"Gr\u00f6ne J-H, Kirchertz EJ, Rieger J (1981) M\u00f6gliche Komplikationen und Probleme der Captopriltherapie bei Hypertonikern mit ausgepr\u00e4gten Gef\u00e4\u00dfsch\u00e4den. Therapiewoche 31:5280\u20135287","journal-title":"Therapiewoche"},{"key":"BF01712054_CR17","first-page":"769","volume":"88","author":"H-J Gr\u00f6ne","year":"1982","unstructured":"Gr\u00f6ne H-J, Helmchen U, Kirchertz EJ, Rieger J, Scheler F (1982) Captopril bei Nierenarterienstenosen. Verh Dtsch Ges Inn Med 88:769\u2013771","journal-title":"Verh Dtsch Ges Inn Med"},{"key":"BF01712054_CR18","first-page":"279","volume":"70","author":"Md Guazzi","year":"1984","unstructured":"Guazzi Md, DeCesare N, Galli C, Salvioni A, Tramontana C, Tambosini G, Bartorelli A (1984) Calcium-channel blockade with nifedipine and angiotensin-converting-enzyme inhibition with Captopril in the therapy of patients with severe primary hypertension. Hypertension 70:279\u2013284","journal-title":"Hypertension"},{"key":"BF01712054_CR19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/clpt.1981.98","volume":"29","author":"L Guillevin","year":"1981","unstructured":"Guillevin L, Lardoux M-D, Corrol P (1981) Effects of Captopril on blood pressure, electrolytes and certain hormones in hypertension. Clin Pharm Therap 29:699\u2013704","journal-title":"Clin Pharm Therap"},{"key":"BF01712054_CR20","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/0002-9149(82)90362-9","volume":"49","author":"J Havetke","year":"1982","unstructured":"Havetke J, Vetter H, Studer A, Greminger P, L\u00fcscher T, Wollnik S, Sigenthaler W, Vetter W (1982) Acute and chronic effects of the angiotensin-converting-enzyme inhibitor Captopril in severe hypertension. Am J Cardiol 49:1467\u20131474","journal-title":"Am J Cardiol"},{"issue":"Suppl 12","key":"BF01712054_CR21","first-page":"S 198","volume":"22","author":"U Helmchen","year":"1982","unstructured":"Helmchen U, Gr\u00f6ne H-J, Kirchertz EJ, Bader H, Bohle RM, Kneissler U, Khosla MC (1982) Contrasting renal effects of different antihypertensive agents in hypertensive rats with bilaterally constricted renal arteries. Kid Int 22 (Suppl 12) S 198-S205","journal-title":"Kid Int"},{"key":"BF01712054_CR22","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/bmj.286.6368.832","volume":"286","author":"GP Hodsman","year":"1983","unstructured":"Hodsman GP, Isles CG, Murray GD, Usterwood TP, Webb DJ, Robertson JIS (1983) Factors related to first dose hypotensive effect of Captopril: prediction and treatment. Brit Med J 286:832\u2013887","journal-title":"Brit Med J"},{"key":"BF01712054_CR23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/bmj.287.6396.851","volume":"287","author":"GP Hodsman","year":"1983","unstructured":"Hodsman GP, Robertson JIS (1983) Captopril: five years on. Brit Med J 287:851\u2013852","journal-title":"Brit Med J"},{"key":"BF01712054_CR24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM198302173080706","volume":"308","author":"DE Hricik","year":"1983","unstructured":"Hricik DE, Browning PJ, Kopelman R, Goorno WE, Madias NE, Dzau VJ (1983) Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenosis or renal-artery stenosis in a solitary kidney. N Engl J Med 308:373\u2013376","journal-title":"N Engl J Med"},{"key":"BF01712054_CR25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.0954-6820.1981.tb11586.x","volume":"209","author":"BE Karlberg","year":"1981","unstructured":"Karlberg BE, Asplund J, Nilsson OR, Weltre S, \u00d6hman KP (1981) Captopril an orally active converting enzyme inhibitor in the treatment of primary hypertension. Acta Med Scand 209:245\u2013252","journal-title":"Acta Med Scand"},{"key":"BF01712054_CR26","doi-asserted-by":"crossref","first-page":"133S","DOI":"10.1111\/j.1365-2125.1982.tb02070.x","volume":"14","author":"BE Karlberg","year":"1982","unstructured":"Karlberg BE, Asplund J, Weltre S, \u00d6hman KP, Nilsson OR (1982) Long-term experiance of Captopril in the treatment of primary (essential) hypertension. Br J Clin Pharmacol 14:133S-137S","journal-title":"Br J Clin Pharmacol"},{"key":"BF01712054_CR27","first-page":"5252","volume":"31","author":"EJ Kirchertz","year":"1981","unstructured":"Kirchertz EJ, Scheler F (1981) Klinisch-praktische Aspekte der Therapie mit Captopril. Therapiewoche 31:5252\u20135323","journal-title":"Therapiewoche"},{"key":"BF01712054_CR28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/014107688507800504","volume":"78","author":"MS Laher","year":"1985","unstructured":"Laher MS, Donohoe JFD, O'Regan P, Counihan TB (1985) Captopril for refractory hypertension in patients with impaired renal function. J Royal Soc Med 78:367\u2013372","journal-title":"J Royal Soc Med"},{"key":"BF01712054_CR29","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/01.HYP.2.4.586","volume":"2","author":"JH Laragh","year":"1980","unstructured":"Laragh JH, Case DB, Atlas SA, Sealey JE (1980) Cantopril compared with other antirenin system agents, in: Hypertensive Patients: Its Triphasic Effects on Blood Pressure and Its Use to Identify and Treatment the Renin Factor. Hypertension 2:586\u2013593","journal-title":"Hypertension"},{"key":"BF01712054_CR30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0002-9343(73)90130-7","volume":"55","author":"EA Lew","year":"1973","unstructured":"Lew EA (1973) High blood pressure, other risk factors and longevity: The insurance viewpoint. Am J Med 55:281\u2013294","journal-title":"Am J Med"},{"key":"BF01712054_CR31","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/0002-9149(82)90390-3","volume":"49","author":"P Lijnen","year":"1982","unstructured":"Lijnen P, Staessen J, Fagand R, Amery A (1982) Increase in plasma aldosterone during prolonged captopril treatment. Am J Cardiol 49:1561\u20131563","journal-title":"Am J Cardiol"},{"key":"BF01712054_CR32","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/bmj.284.6317.693","volume":"284","author":"GA MacGregor","year":"1982","unstructured":"MacGregor GA, Markandu ND, Banks RA et al. (1982) Captopril in essential hypertension: Contrasting effects of adding hydrochlorothiazid or propanolol. Br Med J Clin Res 284:693\u2013696","journal-title":"Br Med J Clin Res"},{"key":"BF01712054_CR33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.0954-6820.1984.tb03770.x","volume":"216","author":"P \u00d6hman","year":"1984","unstructured":"\u00d6hman P, Aurell M, Asplund J, Conradsson T, Delin K, Forslund T, Fyhrquist F, Frithz G, Herlitz H, Karlberg B, Nilsson O, Rhyden L, Welte S (1984) A long-term followup of patients with essential hypertension treated with captopril. Acta Med Scand 216:53\u201356","journal-title":"Acta Med Scand"},{"key":"BF01712054_CR34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1055\/s-2008-1070696","volume":"105","author":"A Overlack","year":"1980","unstructured":"Overlack A, Stumpe KO, Heck I, Kr\u00fcck F (1980) Neues Prinzip in der Langzeitbehandlung der essentiellen Hypertension. Dtsch Med Wochenschr 105:505\u2013509","journal-title":"Dtsch Med Wochenschr"},{"key":"BF01712054_CR35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/oxfordjournals.eurheartj.a061706","volume":"5","author":"GM Patrassi","year":"1984","unstructured":"Patrassi GM, Fallo F, Martinelli S, Mankro F, Boeri G, Givolami A (1984) The contact plase of blood coagulation and renin activation in essential hypertension before and after Captopril. Euro Heart J 5:561\u2013567","journal-title":"Euro Heart J"},{"key":"BF01712054_CR36","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jama.1969.03160310078016","volume":"210","author":"M Perry","year":"1969","unstructured":"Perry M, Wessler S (1969) Survival of treated hypertensive patients. JAMA 210:890\u2013895","journal-title":"JAMA"},{"key":"BF01712054_CR37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.7326\/0003-4819-102-1-56","volume":"102","author":"J Rahmat","year":"1985","unstructured":"Rahmat J, Gelfand RL, Gelfand MC, Winchester JF, Schreiner GE, Zimmermann HJ (1985) Captopril-associated cholestatic Jaundice. Ann Intern Med 102:56\u201358","journal-title":"Ann Intern Med"},{"key":"BF01712054_CR38","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0002-9149(82)90363-0","volume":"49","author":"AEG Raine","year":"1982","unstructured":"Raine AEG, Ledingham JGG (1982) Clinical experience with Captopril in the treatment of severe drug-resistant hypertension. Am J Cardio 49:1475\u20131479","journal-title":"Am J Cardio"},{"key":"BF01712054_CR39","first-page":"127","volume":"23","author":"F Scheler","year":"1982","unstructured":"Scheler F, Gr\u00f6ne H-J (1982) Typische Risiken bei der Behandlung der arteriellen Hypertonie. Internist 23:127\u2013132","journal-title":"Internist"},{"key":"BF01712054_CR40","first-page":"398","volume":"25","author":"F Scheler","year":"1984","unstructured":"Scheler F, Valentin R (1984) Kritische Bemerkungen zur Hochdrucktherapie. Internist 25:398\u2013403","journal-title":"Internist"},{"key":"BF01712054_CR41","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/BF01716802","volume":"60","author":"J Schrader","year":"1982","unstructured":"Schrader J, K\u00f6stering H, Gr\u00f6ne H-J, Kirchertz EJ, Scheler F (1982) Effects of the converting-enzyme-inhibitor Captopril on blood coagulation and fibrinolysis in man. Klin Wochenschr 60:687\u2013690","journal-title":"Klin Wochenschr"},{"key":"BF01712054_CR42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00544006","volume":"25","author":"YK Seedat","year":"1983","unstructured":"Seedat YK, Rawat R (1983) Captopril combined with Minoxidil, Betablocker and Furosemid in the treatment of refractory hypertension. Eur J Clin Pharmacol 25:9\u201311","journal-title":"Eur J Clin Pharmacol"},{"key":"BF01712054_CR43","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/01.CIR.23.5.697","volume":"23","author":"M Sokolow","year":"1961","unstructured":"Sokolow M, Perloff D (1961) The prognosis of essential hypertension treated conservatively. Circulation 23:697\u2013713","journal-title":"Circulation"},{"key":"BF01712054_CR44","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(79)91274-1","volume":"I","author":"I Stewart","year":"1979","unstructured":"Stewart I, Mc DG (1979) Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet I:861\u2013865","journal-title":"Lancet"},{"key":"BF01712054_CR45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF01731655","volume":"63","author":"M Stimpel","year":"1985","unstructured":"Stimpel M, Velter W, Groth H, Greminger P, Vetter H (1985) Captopril before and after Spironolactone therapy in primary aldosteronism. Klin Wochenschr 63:361\u2013363","journal-title":"Klin Wochenschr"},{"issue":"Suppl II","key":"BF01712054_CR46","first-page":"154","volume":"5","author":"M Stornello","year":"1983","unstructured":"Stornello M, DiRao G, Iachello M, Pisani K, Scapellato L, Pedrinelli R, Salvetti A (1983) Hemodynamic and humoral interactions between captopril and nifedipine. Hypertension 5 (Suppl II):154\u2013156","journal-title":"Hypertension"},{"key":"BF01712054_CR47","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/01.CIR.53.4.720","volume":"53","author":"S Strandgaard","year":"1976","unstructured":"Strandgaard S, Olesen J, Skinh\u00f6g E, Lassen NA (1976) Autoregulation of cerebral blood flow in hypertensive patients. Circulation 53:720\u2013727","journal-title":"Circulation"},{"key":"BF01712054_CR48","first-page":"3290","volume":"34","author":"KO Stumpe","year":"1984","unstructured":"Stumpe KO, Kolloch K, Overlack A (1984) Captopril und Enalapril: Therapeutische Effektivit\u00e4t und Sicherheit. Therapiewoche 34:3290\u20133298","journal-title":"Therapiewoche"},{"key":"BF01712054_CR49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM197408152910703","volume":"291","author":"J Taguchi","year":"1974","unstructured":"Taguchi J, Freis ED (1974) Partial reduction of blood pressure and prevention of complications in hypertension. N Engl J Med 291:329\u2013331","journal-title":"N Engl J Med"},{"key":"BF01712054_CR50","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/archinte.1984.04400010055010","volume":"144","author":"Veterans Administration Cooperative Study Group on Antihypertensive Agents","year":"1984","unstructured":"Veterans Administration Cooperative Study Group on Antihypertensive Agents (1984) Low-dose Captopril for the treatment of mild to moderate hypertension. Arch Intern Med 144:1947\u20131953","journal-title":"Arch Intern Med"},{"key":"BF01712054_CR51","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM198201283060405","volume":"306","author":"DG Vidt","year":"1982","unstructured":"Vidt DG, Bravoe EC, Fouad FM (1982) Captopil. N Engl J Med 306:214\u2013219","journal-title":"N Engl J Med"},{"issue":"Suppl 13","key":"BF01712054_CR52","first-page":"III-132","volume":"5","author":"MH Weinberger","year":"1983","unstructured":"Weinberger MH (1983) Influence of an angiotensin-converting-enzyme inhibitor on diuretic-induced metabolic effects in hypertension. Hypertension 5 (Suppl 13):III-132\u2013III-138","journal-title":"Hypertension"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01712054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01712054\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01712054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T12:47:46Z","timestamp":1557319666000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01712054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,8]]},"references-count":52,"journal-issue":{"issue":"15","published-print":{"date-parts":[[1986,8]]}},"alternative-id":["BF01712054"],"URL":"https:\/\/doi.org\/10.1007\/bf01712054","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,8]]}}}